Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 35885.24 | 180 / 180 | 99% | 112.40 | 426 / 430 |
breast | 100% | 23180.92 | 459 / 459 | 99% | 88.81 | 1104 / 1118 |
lung | 100% | 22732.69 | 576 / 578 | 99% | 116.22 | 1143 / 1155 |
esophagus | 98% | 23251.66 | 1423 / 1445 | 100% | 169.77 | 183 / 183 |
uterus | 99% | 23935.02 | 169 / 170 | 99% | 125.80 | 454 / 459 |
bladder | 100% | 24103.38 | 21 / 21 | 98% | 112.78 | 495 / 504 |
stomach | 99% | 18112.04 | 356 / 359 | 99% | 88.41 | 282 / 286 |
intestine | 99% | 17685.03 | 952 / 966 | 99% | 79.35 | 520 / 527 |
kidney | 96% | 13225.71 | 85 / 89 | 99% | 126.36 | 890 / 901 |
prostate | 97% | 15593.29 | 237 / 245 | 96% | 59.21 | 480 / 502 |
adrenal gland | 100% | 44711.59 | 258 / 258 | 85% | 92.02 | 196 / 230 |
thymus | 95% | 10643.41 | 619 / 653 | 85% | 49.59 | 514 / 605 |
skin | 100% | 25260.32 | 1809 / 1809 | 67% | 29.39 | 316 / 472 |
pancreas | 45% | 3645.91 | 148 / 328 | 96% | 101.64 | 170 / 178 |
adipose | 100% | 33760.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 37.94 | 1 / 1 |
blood vessel | 100% | 32671.13 | 1334 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 136.89 | 44 / 45 |
spleen | 90% | 9108.16 | 216 / 241 | 0% | 0 | 0 / 0 |
muscle | 89% | 17071.87 | 716 / 803 | 0% | 0 | 0 / 0 |
brain | 25% | 1758.23 | 665 / 2642 | 60% | 28.26 | 422 / 705 |
heart | 83% | 10930.19 | 711 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 80% | 19394.10 | 739 / 929 | 0% | 0 | 0 / 0 |
liver | 33% | 3026.78 | 75 / 226 | 39% | 18.07 | 160 / 406 |
lymph node | 0% | 0 | 0 / 0 | 24% | 7.79 | 7 / 29 |
eye | 0% | 0 | 0 / 0 | 15% | 4.08 | 12 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
GO_0003417 | Biological process | growth plate cartilage development |
GO_0030223 | Biological process | neutrophil differentiation |
GO_0140459 | Biological process | response to Gram-positive bacterium |
GO_1990823 | Biological process | response to leukemia inhibitory factor |
GO_0008219 | Biological process | cell death |
GO_0030316 | Biological process | osteoclast differentiation |
GO_1904760 | Biological process | regulation of myofibroblast differentiation |
GO_0045087 | Biological process | innate immune response |
GO_0030225 | Biological process | macrophage differentiation |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0002062 | Biological process | chondrocyte differentiation |
GO_0035988 | Biological process | chondrocyte proliferation |
GO_0035264 | Biological process | multicellular organism growth |
GO_0060427 | Biological process | lung connective tissue development |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0040014 | Biological process | regulation of multicellular organism growth |
GO_0001865 | Biological process | NK T cell differentiation |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0002437 | Biological process | inflammatory response to antigenic stimulus |
GO_0048873 | Biological process | homeostasis of number of cells within a tissue |
GO_0036446 | Biological process | myofibroblast differentiation |
GO_0048771 | Biological process | tissue remodeling |
GO_1904975 | Biological process | response to bleomycin |
GO_0060613 | Biological process | fat pad development |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0098760 | Biological process | response to interleukin-7 |
GO_0001666 | Biological process | response to hypoxia |
GO_0030282 | Biological process | bone mineralization |
GO_1901142 | Biological process | insulin metabolic process |
GO_0003334 | Biological process | keratinocyte development |
GO_0042100 | Biological process | B cell proliferation |
GO_0010467 | Biological process | gene expression |
GO_0000902 | Biological process | cell morphogenesis |
GO_0061144 | Biological process | alveolar secondary septum development |
GO_0048745 | Biological process | smooth muscle tissue development |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0035962 | Biological process | response to interleukin-13 |
GO_0070254 | Biological process | mucus secretion |
GO_1904606 | Biological process | fat cell apoptotic process |
GO_0032964 | Biological process | collagen biosynthetic process |
GO_0030183 | Biological process | B cell differentiation |
GO_0042593 | Biological process | glucose homeostasis |
GO_0045444 | Biological process | fat cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003682 | Molecular function | chromatin binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FOSL2 |
Protein name | Alternative protein FOSL2 (FOS-like antigen 2, isoform CRA_a) (cDNA: FLJ23306 fis, clone HEP11541) Fos-related antigen 2 (FRA-2) FOS like 2, AP-1 transcription factor subunit |
Synonyms | FLJ23306 FRA2 hCG_1990537 |
Description | FUNCTION: Controls osteoclast survival and size (By similarity). As a dimer with JUN, activates LIF transcription (By similarity). Activates CEBPB transcription in PGE2-activated osteoblasts (By similarity). . |
Accessions | P15408 ENST00000436647.1 Q9H5M2 C9JCN8 ENST00000379619.5 [P15408-2] ENST00000264716.9 [P15408-1] |